Form 4 · Filed Jul 17, 2026, 11:29 PM UTC
INM/InMed Pharmaceuticals Inc.
ADAR1 Capital Management, LLC — 10pct_owner
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | P | buy | 1,000 | $2 | $1,555 | 801,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001940272-26-000010